image: Fluorescence staining for NRF2 (magenta), p53 (green), and nuclei (blue) in normal breast ducts (encircled by extracellular matrix in white) and invading triple-negative breast cancer cells ...

Kuria Therapeutics Completes FDA Pre-IND Consultation for Topical Nrf2 Activator for Corneal Endothelial Disease - Clear path forward to initiate two planned Phase 2 clinical trials with KTX-1161 ...